Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel D'Incan

Showing results (31-40 of 75) with videos related to

Pageof 8
Sort By:
Anticancer Research|January 2, 2010
Phase II trial of the association of a methionine-free diet with cystemustine therapy in melanoma and gliomaEmilie Thivat, Marie-Chantal Farges, Franck Bacin, et al.
The New England Journal of Medicine|February 1, 2002
A comparison of oral and topical corticosteroids in patients with bullous pemphigoidPascal Joly, Jean-Claude Roujeau, Jacques Benichou, et al.
The Oncologist|December 16, 2015
Frequency and Risk Factors for Associated Lymphomas in Patients With Lymphomatoid PapulosisNadège Cordel, Benoît Tressières, Michel D'Incan, et al.
Cancer Immunology, Immunotherapy : CII|May 25, 2020
Immune checkpoint inhibitors reverse tolerogenic mechanisms induced by melanoma targeted radionuclide therapyJacques Rouanet, Valentin Benboubker, Hussein Akil, et al.
The American Journal of Surgical Pathology|April 10, 2020
Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders: A Clinical, Pathologic, and Molecular Study of 60 Cases Presenting With a Single Lesion: A Multicenter Study of the French Cutaneous Lymphoma Study GroupFanny Beltzung, Nicolas Ortonne, Laura Pelletier, et al.
Archives of Dermatology|September 21, 2005
Treatment of early-stage mycosis fungoides with twice-weekly applications of mechlorethamine and topical corticosteroids: a prospective studyJulie de Quatrebarbes, Eric Estève, Martine Bagot, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 18, 2017
Characterization of foreign materials in paraffin-embedded pathological specimens using in situ multi-elemental imaging with laser spectroscopyBenoit Busser, Samuel Moncayo, Florian Trichard, et al.
Cancers|April 3, 2021
Efficacy of Targeted Radionuclide Therapy Using [<sup>131</sup>I]ICF01012 in 3D Pigmented BRAF- and NRAS-Mutant Melanoma Models and In Vivo NRAS-Mutant MelanomaHussein Akil, Mercedes Quintana, Jérémy H Raymond, et al.
Science Translational Medicine|August 27, 2010
Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell responseDamien Picard, Baptiste Janela, Vincent Descamps, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 2006
EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndromeFranz Trautinger, Robert Knobler, Rein Willemze, et al.
Pageof 8

Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
Anticancer Research|January 2, 2010
Phase II trial of the association of a methionine-free diet with cystemustine therapy in melanoma and gliomaEmilie Thivat, Marie-Chantal Farges, Franck Bacin, et al.
The New England Journal of Medicine|February 1, 2002
A comparison of oral and topical corticosteroids in patients with bullous pemphigoidPascal Joly, Jean-Claude Roujeau, Jacques Benichou, et al.
The Oncologist|December 16, 2015
Frequency and Risk Factors for Associated Lymphomas in Patients With Lymphomatoid PapulosisNadège Cordel, Benoît Tressières, Michel D'Incan, et al.
Cancer Immunology, Immunotherapy : CII|May 25, 2020
Immune checkpoint inhibitors reverse tolerogenic mechanisms induced by melanoma targeted radionuclide therapyJacques Rouanet, Valentin Benboubker, Hussein Akil, et al.
The American Journal of Surgical Pathology|April 10, 2020
Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders: A Clinical, Pathologic, and Molecular Study of 60 Cases Presenting With a Single Lesion: A Multicenter Study of the French Cutaneous Lymphoma Study GroupFanny Beltzung, Nicolas Ortonne, Laura Pelletier, et al.
Archives of Dermatology|September 21, 2005
Treatment of early-stage mycosis fungoides with twice-weekly applications of mechlorethamine and topical corticosteroids: a prospective studyJulie de Quatrebarbes, Eric Estève, Martine Bagot, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 18, 2017
Characterization of foreign materials in paraffin-embedded pathological specimens using in situ multi-elemental imaging with laser spectroscopyBenoit Busser, Samuel Moncayo, Florian Trichard, et al.
Cancers|April 3, 2021
Efficacy of Targeted Radionuclide Therapy Using [<sup>131</sup>I]ICF01012 in 3D Pigmented BRAF- and NRAS-Mutant Melanoma Models and In Vivo NRAS-Mutant MelanomaHussein Akil, Mercedes Quintana, Jérémy H Raymond, et al.
Science Translational Medicine|August 27, 2010
Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell responseDamien Picard, Baptiste Janela, Vincent Descamps, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 2006
EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndromeFranz Trautinger, Robert Knobler, Rein Willemze, et al.
Pageof 8